Testosterone injection - Chong Kun Dang Pharmaceutical
Alternative Names: CKD-845Latest Information Update: 28 Dec 2023
At a glance
- Originator Chong Kun Dang
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypogonadism
Most Recent Events
- 28 Dec 2023 No recent reports of development identified for phase-I development in Hypogonadism in South Korea (IM, Injection)
- 07 Jun 2022 Chong Kun Dang Pharmaceutical completes a phase I trial in Hypogonadism in South Korea (IM) (NCT04673682)
- 16 Nov 2020 Phase-I clinical trials in Hypogonadism in South Korea (IM) (NCT04673682)